James Dowdle

James (Jim) Dowdle, PhD, currently serves as the Medical Affairs Training Lead and previously held roles as a Senior Medical Science Liaison and Medical Science Liaison at United Therapeutics Corporation since April 2021. Prior experience includes serving as a Medical Science Liaison at QED Therapeutics and Biofrontera Group, and completing a Post-Doctoral Fellowship at The Ohio State University Wexner Medical Center, where research focused on gene identification in tumor microenvironments. James earned a PhD in Molecular Biology from Gerstner Sloan-Kettering and a BS in Biotechnology from Rochester Institute of Technology. Notable research achievements include elucidating chromatin remodeling factors in spermatogenesis and providing experimental support in cancer research at MIT.